<sup>18</sup>F-PSMA-1007 salivary gland dosimetry: comparison between different methods for dose calculation and assessment of inter- and intra-patient variability.

Détails

Ressource 1Télécharger: Pistone_2023_Phys._Med._Biol._68_085015.pdf (3333.59 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_C0193E521227
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
<sup>18</sup>F-PSMA-1007 salivary gland dosimetry: comparison between different methods for dose calculation and assessment of inter- and intra-patient variability.
Périodique
Physics in medicine and biology
Auteur⸱e⸱s
Pistone D., Gnesin S., Auditore L., Italiano A., Cascini G.L., Amato E., Cicone F.
ISSN
1361-6560 (Electronic)
ISSN-L
0031-9155
Statut éditorial
Publié
Date de publication
07/04/2023
Peer-reviewed
Oui
Volume
68
Numéro
8
Langue
anglais
Notes
Publication types: Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
Objective. Simplified calculation approaches and geometries are usually adopted for salivary glands (SGs) dosimetry. Our aims were (i) to compare different dosimetry methods to calculate SGs absorbed doses (ADs) following [ <sup>18</sup> F]-PSMA-1007 injection, and (ii) to assess the AD variation across patients and single SG components. Approach. Five patients with prostate cancer underwent sequential positron-emission tomography/computed tomography (PET/CT) acquisitions of the head and neck, 0.5, 2 and 4 h after [ <sup>18</sup> F]-PSMA-1007 injection. Parotid and submandibular glands were segmented on CT to derive SGs volumes and masses, while PET images were used to derive Time-Integrated Activity Coefficients. Average ADs to single SG components or total SG (tSG) were calculated with the following methods: (i) direct Monte Carlo simulation with GATE/GEANT4 considering radioactivity in the entire PET/CT field-of-view (MC) or in the SGs only (MCsgo); (ii) spherical model (SM) of OLINDA/EXM 2.1, adopting either patient-specific or standard ICRP89 organ masses (SMstd); (iii) ellipsoidal model (EM); (iv) MIRD approach with organS-factors from OLINDA/EXM 2.1 and OpenDose collaboration, with or without contribution from cross irradiation originating outside the SGs. The maximum percent AD difference across SG components (δ <sub>max</sub> ) and across patients (Δ <sub>max</sub> ) were calculated.Main results. Compared to MC, ADs to single SG components were significantly underestimated by all methods (average relative differences ranging between -11.9% and -30.5%).δ <sub>max</sub> values were never below 25%. The highestδ <sub>max</sub> (=702%) was obtained with SMstd. Concerning tSG, results within 10% of the MC were obtained only if cross-irradiation from the remainder of the body or from the remainder of the head was accounted for. The Δ <sub>max</sub> ranged between 58% and 78% across patients.Significance. Simple geometrical models for SG dosimetry considerably underestimated ADs compared to MC, particularly if neglecting cross-irradiation from neighboring regions. Specific masses of single SG components should always be considered given their large intra- and inter-patient variability.
Mots-clé
Humans, Male, Oligopeptides, Positron Emission Tomography Computed Tomography, Radiometry/methods, Radiopharmaceuticals, Salivary Glands/diagnostic imaging, GATE, Monte Carlo, PSMA, internal dosimetry, parotids, salivary glands, submandibular glands
Pubmed
Web of science
Open Access
Oui
Création de la notice
24/03/2023 12:34
Dernière modification de la notice
18/11/2023 8:09
Données d'usage